CN102362950A - Traditional Chinese medicine for treating leucoderma - Google Patents

Traditional Chinese medicine for treating leucoderma Download PDF

Info

Publication number
CN102362950A
CN102362950A CN2011101698286A CN201110169828A CN102362950A CN 102362950 A CN102362950 A CN 102362950A CN 2011101698286 A CN2011101698286 A CN 2011101698286A CN 201110169828 A CN201110169828 A CN 201110169828A CN 102362950 A CN102362950 A CN 102362950A
Authority
CN
China
Prior art keywords
parts
radix
fructus
chinese medicine
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011101698286A
Other languages
Chinese (zh)
Inventor
王莲芬
渠淑敏
董娜
吴国敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011101698286A priority Critical patent/CN102362950A/en
Publication of CN102362950A publication Critical patent/CN102362950A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to traditional Chinese medicine for treating leucoderma, which is characterized in that eclipta alba, angelica root, angelica, polygonum multiflorum, astragalus campanulatus R.Brown, ligusticum, tribulus terrestris, ligustrum lucidum, nepeta, lithospermum, paris polyphylla, divaricate saposhnikovia root, saffron crocus, purple salvia miltiorrhiza, radix sophorae flavescentis and fructus psoraleae are prepared into various oral preparations according to the conventional pharmacy method. The traditional Chinese medicine has the advantages that the functions of warming and nourishing the liver and the kidney, dispelling the wind, eliminating dampness, regulating qi and blood, clearing and activating the channels and collaterals, activating blood, dissolving stasis and regulating the immunity are realized, the effect of improving the skin micro circulation is reached, the curative effect on the prevention and the treatment of the leucoderma is definite, and the taking is convenient.

Description

The leukodermic Chinese medicine of a kind of treatment
Technical field
The present invention relates to skin class treatment of diseases technical field, relate in particular to a kind of technical field of Chinese medicines of treating the vitiligo disease.
Background technology
Vitiligo is a kind of common posteriority, circumscribed depigmentation dermatoses, can betide any age, is more common in child and youth.The sick limitation decolouring speckle that decreases to differing in size, clear-cut margin, on every side with the healthy skin intersection, color of the leather is denseer; Kainogenesis damages common have temporary inflammatory halo, number or single-shot or pilosity on every side, can merge each other in flakes, and the affected part hair can bleach, and does not have any subjective symptoms, and damaging part has bright gargalesthesia after the Exposure to Sunlight.Primary disease is relevant with various autoimmune property disease, like some patients with vitiligo or its relatives, can be associated with hyperthyroidism and go down, diabetes etc.; The organ specific antibody of finding thyroid, stomach, adrenal tissue in some patient's the blood exists.Primary disease often has family history, has family's genetic predisposition.In addition, with body in copper, zinc ion content lower relevant.The patient is many to increase with perspiration, the performance increase in temperature, and diseases such as bleeding time prolongation, the reason that takes place as the vitiligo disease belongs to blood deficiency and blood stasis wind-engaging person more.
At present, it is a lot of to treat this sick method and medicine, but can not reach ideal effect, Therapeutic Method such as " laser ", " skin-grafting ", " freezing " for example, and not only weak curative effect is returned skin and is stayed scar; Some medicine such as patent medicine: the speckle removing ball, remove Bai Su, white macula tincture etc.; These medicines existence take effect slowly, the course of treatment is long; Cure rate low with shortcoming such as relapse rate height; The medicine that has also has irritated and slight toxic reaction, and the medicine that also has is prone to cause side effect such as liver,kidney,spleen enlargement, brings misery to the patient.
Summary of the invention
Technical problem to be solved by this invention provides a kind of to eliminate patient's illness, and the promotion physical and mental health has the leukodermic Chinese medicine of treatment that the patient takes medicine conveniently, curative effect is fast, have no side effect simultaneously.
For solving the problems of the technologies described above; The present invention adopts following technical scheme: the leukodermic Chinese medicine of a kind of treatment, its special character is to be processed by the medicine of following weight proportioning: Herba Ecliptae 30-60 part, Radix Angelicae Dahuricae 30-60 part, Radix Angelicae Sinensis 10-30 part, Radix Polygoni Multiflori 30-60 part, SEMEN ASTRAGALI COMPLANATI 30-60 part, Rhizoma Chuanxiong 15-45 part, Fructus Tribuli 30-60 part, Fructus Ligustri Lucidi 10-30 part, Herba Schizonepetae 10-30 part, Radix Arnebiae (Radix Lithospermi) 15-45 part, Rhizoma Paridis 10-30 part, windproof 10-30 part, Stigma Croci 1-2 part, Radix Salviae Miltiorrhizae 10-30 part, Radix Sophorae Flavescentis 10-30 part, Fructus Psoraleae 30-50 part.
For further solving the problems of the technologies described above; The medicine of the above-mentioned weight proportion of the leukodermic Chinese medicine of treatment of the present invention, its preferred version is: Herba Ecliptae 40-50 part, Radix Angelicae Dahuricae 40-50 part, Radix Angelicae Sinensis 15-25 part, Radix Polygoni Multiflori 40-50 part, SEMEN ASTRAGALI COMPLANATI 40-50 part, Rhizoma Chuanxiong 25-35 part, Fructus Tribuli 40-50 part, Fructus Ligustri Lucidi 15-25 part, Herba Schizonepetae 15-25 part, Radix Arnebiae (Radix Lithospermi) 25-35 part, Rhizoma Paridis 15-25 part, windproof 15-25 part, Stigma Croci 1.2-1.8 part, Radix Salviae Miltiorrhizae 15-25 part, Radix Sophorae Flavescentis 15-25 part, Fructus Psoraleae 35-45 part.
For further solving the problems of the technologies described above; The medicine of the above-mentioned weight proportion of the leukodermic Chinese medicine of treatment of the present invention, its preferred plan is: 45 parts of Herba Ecliptaes, 45 parts of the Radixs Angelicae Dahuricae, 20 parts of Radix Angelicae Sinensis, 45 parts of Radix Polygoni Multiflori, 45 parts of SEMEN ASTRAGALI COMPLANATIs, 30 parts of Rhizoma Chuanxiong, 45 parts of Fructus Tribulis, 20 parts of Fructus Ligustri Lucidi, 20 parts of Herba Schizonepetae, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Rhizoma Paridis, windproof 20 parts, 1.5 parts of Stigma Crocis, 20 parts of Radix Salviae Miltiorrhizae, 20 parts of Radix Sophorae Flavescentiss, 40 parts of Fructus Psoraleaes.
Above-mentioned described Chinese medicine is processed pill, sublimed preparation, powder, tablet, unguentum, decoction and the different oral medicine dosage form of capsule dress powder according to the conventional technology of preparing of Chinese medicine.
Above-mentioned described Chinese medicine also contains drug excipient.
The principles of formulating prescriptions of Chinese medicine of the present invention are: nourish liver spleen, replenishing QI to invigorate the spleen, nourshing blood and promoting blood circulation, dredge the meridian passage, blood circulation promoting and blood stasis dispelling, set upright and get rid of evils, regulate immunologic function, improve skin microcirculation, reach the leukodermic purpose of treatment.The present invention has proper, the reasonable recipe of compatibility of drugs, and the effect of its said each herbal medicine is:
Herba Ecliptae: another name: Nanjing grass, Alternanthera sessilis (L.) DC., yerbadetajo seed, Fructus seu radix camptothecae acuminatae (Fructus Camptothecae Acuminatae), Herba Ecliptae, Fructus seu radix camptothecae acuminatae (Fructus Camptothecae Acuminatae) are fluffy etc. in vain; Sweet in the mouth, acid, cool in nature; Return liver, kidney channel, have liver and kidney tonifying; The effect of cooling blood for hemostasis; Main deficiency of the liver and kindey, have a dizzy spell, early whitening of beard and hair, haematemesis, spitting of blood, epistaxis, have blood in stool, dysentery, collapse, disease such as leakage, traumatic hemorrhage.
The Radix Angelicae Dahuricae: acrid in the mouth, warm in nature.Go into lung, stomach warp.The effect of the Radix Angelicae Dahuricae, expelling pathogenic wind from the body surface, pain relieving, detumescence and apocenosis, dampness leukorrhagia stopping.
Radix Angelicae Sinensis: hot, the little hardship, warm in nature of sweet in the mouth, return liver spleen heart channel, having enriches blood invigorate blood circulation he, the effect of menstruction regulating and pain relieving, these the article diseases such as row is stagnant, menstruction regulating and pain relieving of can nourishing blood with the Rhizoma Chuanxiong compatibility;
Radix Polygoni Multiflori: sweetness and bitterness, puckery, slightly warm in nature is returned liver, kidney channel, has nourishing the blood and yin, loosening bowel to relieve constipation, preventing the attack (or recurrence) of malaria, dispels the wind, the antidotal effect.Cure mainly a little less than the waist knee joint acid of blood deficiency Light-headedness, cardiopalmus, insomnia, the hepatic and renal YIN deficiency; Early whitening of beard and hair, tinnitus, seminal emission, dryness of the intestine constipation; The chronic malaria body is empty; Diseases such as rubella pruritus, carbuncle sore, scrofula, hemorrhoid.
SEMEN ASTRAGALI COMPLANATI: have another name called: Semen Astragali Complanati.Mature seed for the leguminous plant astragatus complanatus.Be divided into Semen Astragali Complanati, salt SEMEN ASTRAGALI COMPLANATI, fry Semen Astragali Complanati according to different concocting methods, concoct in the back storage drying receptacle, airtight, put the aeration-drying part.Warm in nature, sweet in the mouth, little hardship are returned liver, kidney channel, the matter lubricant nature with; Has the temperature compensation Liver and kidney, controlling nocturnal emission with astringent drugs, reducing urination, the effect that makes eye bright.Be used for lumbago due to renal deficiency, seminal emission premature ejaculation, nebulousurine leukorrhagia, dribbling urination, diseases such as dizzy blurred vision.
Rhizoma Chuanxiong: acrid in the mouth, warm in nature, the effect of promoting flow of QI and blood, wind-expelling pain-stopping is arranged, be used to treat diseases such as menoxenia, amenorrhea dysmenorrhea 、 WEIJIA stomachache, costa sternales twinge, treating swelling and pain by traumatic injury, headache, rheumatic arthralgia;
Fructus Tribuli: another name, thatch, Fructus Tribuli, Fructus Tribuli, Fructus Atriplicis Sibiricae, society Fructus Tribuli soil Fructus Tribuli, Fructus Atriplicis Sibiricae, drought grass, triangle Fructus Tribuli, three JIAOCI, anistree thorn, puncture frame, wild Pedicellus et Pericarpium Trapae, Pedicellus et Pericarpium Trapae thorn etc.; Bitter in the mouth; Hot; Property is put down; Return liver, lung, kidney, heart channel; Effect: suppressing the hyperactive liver, resolving depression, dispelling pathogenic wind for improving eyesight; Cure mainly headache, dizzy, distending pain in the chest and hypochondrium, distending pain of the breast, breast and close diseases such as obstructed, amenorrhea, conjunctival congestion cataracta, rubella pruritus, vitiligo, skin ulcer cellulitis, scrofula.
Fructus Ligustri Lucidi: sweet-bitter flavor, cold nature, return the Liver and kidney warp, have nourishing the liver and kidney, the effect that black hair makes eye bright, these article go into Liver and kidney can benefiting essence-blood, black beard and hair, Pingyin fire, reducing the asthenic fever, is usually used in treating deficiency of the liver and kindey and causes disease;
Herba Schizonepetae: acrid in the mouth, slightly warm in nature, return lung, Liver Channel, have the diffusing wind that induces sweat, rash, the skin ulcer that disappears, hemostatic effect, be usually used in treatment flu, measles pass through send out smooth, have blood in stool, diseases such as metrorrhagia, epistaxis.
Radix Arnebiae (Radix Lithospermi): cold in nature, bitter in the mouth, sweet, flat, be included into the heart, Liver Channel.Effect: removing heat from blood, invigorate blood circulation heat clearing away, detoxifcation.Cure mainly warm macule, jaundice due to damp-heat, purpura tells, nosebleed, hematuria, stranguria with turbid discharge, constipation with heat retention, burn, eczema, erysipelas, diseases such as carbuncle and ulcer.
Rhizoma Paridis: another name: Rhizoma Paridis, Rhizoma Paridis, Typhonium divaricatum (L.) Decne.Character: tubers is cylindrical, and is much more straight, and minority is crooked.Diameter 1~6cm, long 4.5~12cm.The surface yellowish-brown, the minority taupe, more level and smooth; Cold nature, bitter in the mouth; Slightly poisonous.Function cures mainly: heat-clearing and toxic substances removing, reducing swelling and alleviating pain, cool liver arresting convulsion.Make in furuncle swollen carbuncle, laryngopharynx swelling and pain, venom, fall and pounce on the pain of injury, convulsion with spasms.
Windproof: as acrid in the mouth, sweet, slightly warm in nature, to return bladder, liver, spleen channel, have the effect of expelling pathogenic wind from the body surface, removing dampness to relieve pain, relieving convulsion, be used to treat diseases such as diseases caused by exogenous pathogenic factor exterior syndrome, rubella pruritus, rheumatic arthralgia, tetanus.
Stigma Croci: sweet in the mouth, property are put down, and have the effect of blood circulation promoting and blood stasis dispelling, dispersing stagnation and relieving accumulation of pathogens.Be usually used in treating that the chest and diaphragm painful abdominal mass is vexed, haematemesis, typhoid fever are gone mad, frightenedly be afraid of in a trance, women's amenorrhea, diseases such as postnatal blood stasis stomachache, treating swelling and pain by traumatic injury.
Radix Salviae Miltiorrhizae: have another name called Radix Salviae Miltiorrhizae, Radix Salviae Miltiorrhizae, Radix Salviae Miltiorrhizae, Arisaema balansae Engl. etc.Be the dicotyledon Labiatae, dry root and rhizome.Main product in Anhui, ground such as Henan, Shaanxi.The Radix Salviae Miltiorrhizae that records than the Pharmacopoeia of the People's Republic of China because of its root. little, main again production and marketing Yunnan is so claim Radix Salviae Miltiorrhizae, mildly bitter flavor, cold nature again.Red complexion is gone into heart channel; Have reinforcing the heart, hemopoietic nourishes heart, and decides will, calming heart and tranquilizing mind, and forgetful palpitation with a distress feeling, palpitation with fear is insomnia, tissue regeneration promoting blood, blood stasis removing blood, peaceful tire, stillborn fetus falls.Can support the merit that SIWU TANG is enriched blood simply ".
Radix Sophorae Flavescentis: another name: wild Chinese scholartree, brave man's branch, bitter bone, bone, Chinese scholartree, Albizzia kalkora; Cold in nature, bitter in the mouth, GUIXIN, liver, stomach, large intestine, urinary bladder channel; Effect: heat clearing and damp drying, parasite killing, diuresis.Cure mainly: be used for hematodiarrhoea, have blood in stool, jaundice urine retention, leucorrhea with red and white discharge, swelling of the vulva pudendal pruritus, eczema, eczema, skin pruritus, scabies leprosy; External treatment trichomonal vaginitis.
Fructus Psoraleae: acrid in the mouth, warm in nature, nontoxic; Effect with enriching yin and nourishing kidney is usually used in that Yuanyang declines that damage, five kinds of strain and seven kinds of impairment, lumbago due to renal deficiency, kidney qi deficiency and coldness, vital essence are solid, the enuresis, spleen suffer from a deficiency of the kidney and rush down, watery diarrhea chronic dysentery, pregnant woman's lumbago, fall and weigh down diseases such as lumbago, blood stasis stagnate;
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", and all composition comes from the 5th edition medicine that records of China's " pharmacopeia ", and all medicines have the temperature compensation Liver and kidney mutually and altogether, the wind dehumidifying of loosing; The QI and blood regulating, is set upright and is got rid of evils dredge the meridian passage, blood circulation promoting and blood stasis dispelling, regulates immunologic function; Improve skin microcirculation, promote skin pigment to generate the effect of the white and moist skin that disappears; Treatment and prevention vitiligo, determined curative effect have no side effect various Chinese medicine preparation taking conveniences.
Clinical drug of the present invention uses the result to show to have following advantage:
1, the Chinese medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment and the prevention vitiligo of the Chinese medicine of respectively distinguishing the flavor of, and is harmless to human non-toxic.Acute toxicity test and accumulation toxicity test through white mice and rat show that underproof animal does not see any toxic reaction; Compare zero difference through anatomic observation hemogram, liver function, each organs and tissues morphology finding and matched group, prove that its safety of medicine is reliable.
2, Chinese medicine preparation of the present invention need not decoct, not have bitterness sense; Rich in proteins, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid in the medicine; Also contain various trace elements such as Saponin, plant sterol, calcium; Help absorption of human body, health invigorating, and taking convenience.
But 3, Chinese medicine preparation of the present invention efficacious therapy vitiligo not only; And it is also very obvious to leukodermic preventive effect; Particularly pass through working in coordination with each other between the medicine, strengthen medicine and treat characteristic separately, through dredge the meridian passage and adjusting immunologic function; Improve the intrinsic healthy energy of patient body and physical and mental health and life quality, reached the healing rehabilitation efficacy preferably.
Further specify medicine of the present invention to treatment therapy for vitiligo effect through the clinical practice example below.
One, clinical diagnosis standard:
Leukodermic clinical manifestation is: the skin of any department of whole body all can take place, but originates from solar radiation and the damage by friction portion of being prone to, and also can involve like the inboard mucosa of facial area, cervical region, trunk and extremity, lip, labia, glans penis and foreskin.Most of leukasmus is symmetrically distributed, and also has part patient white macula to distribute along nerve segment.Skin lesion is locality depigmentation speckle, milky, big or small from fingernail to coin, circular, oval or irregular shape.White macula place hair also can bleach.In progressive stage, the decolouring speckle is divided a word with a hyphen at the end of a line to normal skin, and development is very fast, and isomorphic response is arranged, and promptly can form the secondary vitiligo after pressure, friction, the wound.
Can divide three types according to the leukoderma scope with distributing:
1, limitation: skin lesion is confined to a position, can be divided into again: (1) segmental pattern: skin lesion is pressed dermatomere and is distributed; (2) mucosal pattern: only involve mucosa.
2, general hair style: the most common, show as skin lesion and be distributed widely in body surface, can be divided into:
(1) homeliness type: skin lesion is dispersed in and is distributed in the body surface many places;
(2) face acra type: skin lesion is distributed in face and far-end of limb;
(3) mixed type: above-mentioned several kinds of various combinations form, like face acra type+segmental pattern etc.
3, whole body type: whole skin all decolours fully or almost, also has hair to bleach.
Two, case selection
Leukodermic sickness rate is with area, the ethnic group colour of skin and different, and the dark more people's sickness rate of general colour is high more.Prevalence is about 0.1-2% in the population of China, and M-F can be fallen ill from the newborn baby about equally until old every year, but is many with teenager.Put down in writing according to interrelated data: age of onset is in the majority in 10-30 year, accounts for 62.65% of sum, and women's age of onset was than male about 5 years ahead of time.For this reason, case selection is whole cases with door rash prescription on individual diagnosis patient.
Three, curative effect determinate standard
Before the curative effect determinate standard that not have at present the promulgation of formal country, the vitiligo curative effect determinate standard that the present invention adopts (the scientific and technological publishing house of Chen Qin chief editor " research and development of Chinese medicine cosmetic health product " Chinese Medicine 1999 version the 228th page) is:
(1) recovery from illness: the white macula complete obiteration, histopathology of skin's inspection is normal;
(2) produce effects: white macula disappears more than 50%, and white macula disappearance portion of tissue pathological examination is normal;
(3) effective: white macula disappearance person accounts for the 20-50% of former white macula area, or in white macula, sees have than the polychrom island;
(4) invalid: no change or white macula enlarge before and after the treatment.
Four, clinical application method and therapeutic outcome
1, clinical application method
According to patient's sick time, the cause of disease and white macula scope and distribution situation, the component medication:
Take the capsule of embodiment 3, each 3-7 gram, every day 2-3 time, warm water delivery service, take half an hour ante cibum.Two months is a course of treatment, take continuously three the course of treatment observe the curative effect.
2, therapeutic outcome
Amount to 89 examples through clinical diagnosis treatment patients with vitiligo, male's 36 examples, women's 53 examples, the age is 12-50 year.Recovery from illness 58 examples account for 65.2% among the 89 routine patients, and produce effects 23 examples account for 25.8%, and effective 6 examples account for 7%, and invalid 2 examples account for 2%, and total effective rate reaches 98%.After treatment, the patient skin white macula disappears in various degree or fully recover, and patient do not have any untoward reaction, three big routine tests and hepatic and renal function detection do not find any unusually.Fully recover through the patient and to pay a return visit statistics, do not see an example recurrence so far.
The specific embodiment
Embodiment 1
Press the row weight portion and take by weighing each Chinese crude drug: 30 parts of Herba Ecliptaes, 30 parts of the Radixs Angelicae Dahuricae, 10 parts of Radix Angelicae Sinensis, 30 parts of Radix Polygoni Multiflori, 30 parts of SEMEN ASTRAGALI COMPLANATIs, 15 parts of Rhizoma Chuanxiong, 30 parts of Fructus Tribulis, 10 parts of Fructus Ligustri Lucidi, 10 parts of Herba Schizonepetae, 15 parts of Radix Arnebiae (Radix Lithospermi)s, 10 parts of Rhizoma Paridis, windproof 10 parts, 1 part of Stigma Croci, 10 parts of Radix Salviae Miltiorrhizae, 10 parts of Radix Sophorae Flavescentiss, 30 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed sublimed preparation according to the pharmaceutical methods that routine prepares sublimed preparation.
Embodiment 2
Press the row weight portion and take by weighing each medical material: 60 parts of Herba Ecliptaes, 60 parts of the Radixs Angelicae Dahuricae, 30 parts of Radix Angelicae Sinensis, 60 parts of Radix Polygoni Multiflori, 60 parts of SEMEN ASTRAGALI COMPLANATIs, 45 parts of Rhizoma Chuanxiong, 60 parts of Fructus Tribulis, 30 parts of Fructus Ligustri Lucidi, 30 parts of Herba Schizonepetae, 45 parts of Radix Arnebiae (Radix Lithospermi)s, 30 parts of Rhizoma Paridis, windproof 30 parts, 2 parts of Stigma Crocis, 30 parts of Radix Salviae Miltiorrhizae, 30 parts of Radix Sophorae Flavescentiss, 50 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed packed powder according to the pharmaceutical methods that routine prepares powder.
Embodiment 3
Press the row weight portion and take by weighing each medical material: 40 parts of Herba Ecliptaes, 40 parts of the Radixs Angelicae Dahuricae, 15 parts of Radix Angelicae Sinensis, 40 parts of Radix Polygoni Multiflori, 40 parts of SEMEN ASTRAGALI COMPLANATIs, 25 parts of Rhizoma Chuanxiong, 40 parts of Fructus Tribulis, 15 parts of Fructus Ligustri Lucidi, 15 parts of Herba Schizonepetae, 25 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Rhizoma Paridis, windproof 15 parts, 1.2 parts of Stigma Crocis, 15 parts of Radix Salviae Miltiorrhizae, 15 parts of Radix Sophorae Flavescentiss, 35 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed capsule according to the pharmaceutical methods that routine prepares capsule.
Embodiment 4
Press the row weight portion and take by weighing each medical material: 50 parts of Herba Ecliptaes, 50 parts of the Radixs Angelicae Dahuricae, 25 parts of Radix Angelicae Sinensis, 50 parts of Radix Polygoni Multiflori, 50 parts of SEMEN ASTRAGALI COMPLANATIs, 35 parts of Rhizoma Chuanxiong, 50 parts of Fructus Tribulis, 25 parts of Fructus Ligustri Lucidi, 25 parts of Herba Schizonepetae, 35 parts of Radix Arnebiae (Radix Lithospermi)s, 25 parts of Rhizoma Paridis, windproof 25 parts, 1.8 parts of Stigma Crocis, 25 parts of Radix Salviae Miltiorrhizae, 25 parts of Radix Sophorae Flavescentiss, 45 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed tablet according to the pharmaceutical methods that routine prepares tablet; (like conventional tablet, sugar coated tablet, film coated tablet etc.), and give conventional drug excipient (like starch, sucrose, lactose, calcium stearate, magnesium stearate etc.).
Embodiment 5
Press the row weight portion and take by weighing each medical material: 45 parts of Herba Ecliptaes, 45 parts of the Radixs Angelicae Dahuricae, 20 parts of Radix Angelicae Sinensis, 45 parts of Radix Polygoni Multiflori, 45 parts of SEMEN ASTRAGALI COMPLANATIs, 30 parts of Rhizoma Chuanxiong, 45 parts of Fructus Tribulis, 20 parts of Fructus Ligustri Lucidi, 20 parts of Herba Schizonepetae, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Rhizoma Paridis, windproof 20 parts, 1.5 parts of Stigma Crocis, 20 parts of Radix Salviae Miltiorrhizae, 20 parts of Radix Sophorae Flavescentiss, 40 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed pill according to the pharmaceutical methods that routine prepares pill, and give conventional drug excipient.
Embodiment 6
Press the row weight portion and take by weighing each medical material: 42 parts of Herba Ecliptaes, 42 parts of the Radixs Angelicae Dahuricae, 20 parts of Radix Angelicae Sinensis, 42 parts of Radix Polygoni Multiflori, 42 parts of SEMEN ASTRAGALI COMPLANATIs, 30 parts of Rhizoma Chuanxiong, 42 parts of Fructus Tribulis, 22 parts of Fructus Ligustri Lucidi, 22 parts of Herba Schizonepetae, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 22 parts of Rhizoma Paridis, windproof 22 parts, 1.5 parts of Stigma Crocis, 22 parts of Radix Salviae Miltiorrhizae, 22 parts of Radix Sophorae Flavescentiss, 40 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed granule according to the pharmaceutical methods that routine prepares granule.

Claims (5)

1. the leukodermic Chinese medicine of treatment is characterized in that being processed by the medicine of following weight proportioning: Herba Ecliptae 30-60 part, Radix Angelicae Dahuricae 30-60 part, Radix Angelicae Sinensis 10-30 part, Radix Polygoni Multiflori 30-60 part, SEMEN ASTRAGALI COMPLANATI 30-60 part, Rhizoma Chuanxiong 15-45 part, Fructus Tribuli 30-60 part, Fructus Ligustri Lucidi 10-30 part, Herba Schizonepetae 10-30 part, Radix Arnebiae (Radix Lithospermi) 15-45 part, Rhizoma Paridis 10-30 part, windproof 10-30 part, Stigma Croci 1-2 part, Radix Salviae Miltiorrhizae 10-30 part, Radix Sophorae Flavescentis 10-30 part, Fructus Psoraleae 30-50 part.
2. the leukodermic Chinese medicine of treatment according to claim 1 is characterized in that being processed by the medicine of following weight proportioning; Herba Ecliptae 40-50 part, Radix Angelicae Dahuricae 40-50 part, Radix Angelicae Sinensis 15-25 part, Radix Polygoni Multiflori 40-50 part, SEMEN ASTRAGALI COMPLANATI 40-50 part, Rhizoma Chuanxiong 25-35 part, Fructus Tribuli 40-50 part, Fructus Ligustri Lucidi 15-25 part, Herba Schizonepetae 15-25 part, Radix Arnebiae (Radix Lithospermi) 25-35 part, Rhizoma Paridis 15-25 part, windproof 15-25 part, Stigma Croci 1.2-1.8 part, Radix Salviae Miltiorrhizae 15-25 part, Radix Sophorae Flavescentis 15-25 part, Fructus Psoraleae 35-45 part.
3. the leukodermic Chinese medicine of treatment according to claim 1 is characterized in that being processed by the medicine of following weight proportioning: 45 parts of Herba Ecliptaes, 45 parts of the Radixs Angelicae Dahuricae, 20 parts of Radix Angelicae Sinensis, 45 parts of Radix Polygoni Multiflori, 45 parts of SEMEN ASTRAGALI COMPLANATIs, 30 parts of Rhizoma Chuanxiong, 45 parts of Fructus Tribulis, 20 parts of Fructus Ligustri Lucidi, 20 parts of Herba Schizonepetae, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Rhizoma Paridis, windproof 20 parts, 1.5 parts of Stigma Crocis, 20 parts of Radix Salviae Miltiorrhizae, 20 parts of Radix Sophorae Flavescentiss, 40 parts of Fructus Psoraleaes.
4. according to the leukodermic Chinese medicine of the described treatment of arbitrary claim in the claim 1 to 3, it is characterized in that described Chinese patent medicine processes pill, sublimed preparation, powder, tablet, unguentum, decoction and the different oral medicine dosage form of capsule dress powder according to the conventional technology of preparing of Chinese medicine.
5. the leukodermic Chinese medicine of treatment according to claim 4 is characterized in that described Chinese patent medicine also contains drug excipient.
CN2011101698286A 2011-06-15 2011-06-15 Traditional Chinese medicine for treating leucoderma Pending CN102362950A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011101698286A CN102362950A (en) 2011-06-15 2011-06-15 Traditional Chinese medicine for treating leucoderma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011101698286A CN102362950A (en) 2011-06-15 2011-06-15 Traditional Chinese medicine for treating leucoderma

Publications (1)

Publication Number Publication Date
CN102362950A true CN102362950A (en) 2012-02-29

Family

ID=45689566

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011101698286A Pending CN102362950A (en) 2011-06-15 2011-06-15 Traditional Chinese medicine for treating leucoderma

Country Status (1)

Country Link
CN (1) CN102362950A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393903A (en) * 2013-08-06 2013-11-20 董云 Medicament for treating leucoderma
CN103705605A (en) * 2013-12-16 2014-04-09 崔夕军 Traditional Chinese medicine for treating leucoderma
CN103720821A (en) * 2014-01-24 2014-04-16 王兰玲 External ointment for treating vitiligo antigens and preparation method thereof
CN103860930A (en) * 2014-03-19 2014-06-18 李常明 Traditional Chinese medicine composition for effectively treating leucoderma
CN105147954A (en) * 2015-09-29 2015-12-16 成都倍加特生物科技有限公司 Medicine powder for treating leucoderma and preparation method thereof
CN105194227A (en) * 2015-10-30 2015-12-30 吴小斌 Traditional Chinese medicine pills for treating leucoderma and preparation method of traditional Chinese medicine pills
CN105250476A (en) * 2015-11-13 2016-01-20 何江思 Patch used for treating leucoderma and use method thereof
CN106038939A (en) * 2016-07-25 2016-10-26 陈凯 Traditional Chinese medicine for treating leukoderma

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1273847A (en) * 1999-05-14 2000-11-22 王志明 Chinese medicine for treating dermatopathy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1273847A (en) * 1999-05-14 2000-11-22 王志明 Chinese medicine for treating dermatopathy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
乔桂华等主编: "《中医辨证施治皮肤科疑难病》", 30 November 2006, article "第十二章色素障碍性皮肤病", pages: 310-311 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393903A (en) * 2013-08-06 2013-11-20 董云 Medicament for treating leucoderma
CN103393903B (en) * 2013-08-06 2015-02-25 董云 Medicament for treating leucoderma
CN103705605A (en) * 2013-12-16 2014-04-09 崔夕军 Traditional Chinese medicine for treating leucoderma
CN103720821A (en) * 2014-01-24 2014-04-16 王兰玲 External ointment for treating vitiligo antigens and preparation method thereof
CN103720821B (en) * 2014-01-24 2015-08-19 王兰玲 One treats leukodermic external-applied ointment and preparation method
CN103860930A (en) * 2014-03-19 2014-06-18 李常明 Traditional Chinese medicine composition for effectively treating leucoderma
CN103860930B (en) * 2014-03-19 2016-06-01 刘凤伟 The Chinese medicine composition of a kind of effective treatment vitiligo
CN105147954A (en) * 2015-09-29 2015-12-16 成都倍加特生物科技有限公司 Medicine powder for treating leucoderma and preparation method thereof
CN105194227A (en) * 2015-10-30 2015-12-30 吴小斌 Traditional Chinese medicine pills for treating leucoderma and preparation method of traditional Chinese medicine pills
CN105250476A (en) * 2015-11-13 2016-01-20 何江思 Patch used for treating leucoderma and use method thereof
CN106038939A (en) * 2016-07-25 2016-10-26 陈凯 Traditional Chinese medicine for treating leukoderma

Similar Documents

Publication Publication Date Title
CN102416079A (en) Chinese patent medicine for treating leucoderma
CN102362950A (en) Traditional Chinese medicine for treating leucoderma
CN103251867A (en) Chinese herbal compound medicine for treating diabetes mellitus and preparation method thereof
CN103520572A (en) Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition
CN100496585C (en) Chloasma treating Chinese medicine preparation
CN104958607A (en) Traditional Chinese medicine composition for treating burning mouth syndromes of climacteric women and preparation method thereof
CN101912551B (en) Miscarriage-prevention Chinese medicinal composition
CN103432559A (en) Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof
CN101897933B (en) Chinese patent medicament for treating leucoderma
CN104383257A (en) Chinese medicinal preparation for treating xerophthalmia due to liver depression and deficiency of yin
CN102178781B (en) Chinese medicine composition for treating scrotum eczema and preparation method thereof
CN102430013A (en) Chinese medicine for treating vitiligo
CN102430097A (en) Chinese medicine for treating vitiligo
CN103977281A (en) Traditional Chinese medicine composition for treating female endocrine disorders and preparation method thereof
CN102727648A (en) Chinese medicinal composition for treating vitiligo
CN102423433A (en) Traditional Chinese drug mixture for treating psoriasis
CN102406866A (en) Chinese medicinal composition for treating psoriasis
CN104784538A (en) Chinese medicinal preparation for treating diabetes and preparation method
CN102579975B (en) Traditional Chinese medicine mixture for treating psoriasis
CN104906430A (en) Traditional Chinese medicine preparation for treating xerophthalmia and preparation method thereof
CN103330837A (en) Traditional Chinese medicine composition for curing osteoporosis of menopausal women
CN102406865A (en) Chinese medicinal composition for treating psoriasis
CN102406893A (en) Chinese patent medicine for treating psoriasis.
CN102579895B (en) Traditional Chinese medicine composition for treating psoriasis
CN104288581A (en) Traditional Chinese medicine for treating threatened abortion

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120229